Skip to main content

Tumeurs secondaires: l’expérience du cancer du sein

  • Chapter
  • 384 Accesses

Part of the book series: Oncologie pratique ((ONCOLPRAT))

Résumé

Les traitements modernes du cancer du sein ont permis une amélioration de la survie á long terme. La chimiothérapie adjuvante et/ou les nouvelles molécules de traitements ciblés ont permis de prolonger la survie sans récidive et la survie globale (1). La radiothérapie adjuvante joue un rôle essentiel dans la prévention des récidives locorégionales du cancer du sein et son effi cacité a été démontrée dans plusieurs essais randomisés, ainsi que dans la méta-analyse (29). Dans les formes á haut risque de récidive, cette action locorégionale de la radiothérapie se traduit par un bénéfi ce de survie á long terme (9). Plusieurs techniques d’irradiation de plus en plus améliorées ont été développées (1013) pour diminuer la toxicité á court et á long terme (1418). L’hormonothérapie joue également un rôle important dans le traitement de patients présentant des récepteurs á oestrogéne et progestérone positifs (19). L’ensemble de ces traitements est indispensable pour la prise en charge de patientes avec un cancer du sein, mais il peut être responsable de complications á long terme de type tumeurs secondaires. La cancérogenése est multifactorielle: la prédisposition génétique, la chimiothérapie, la radiothérapie, l’hormonothérapie sont connues pour être des facteurs de risque de cancer (14).

This is a preview of subscription content, log in via an institution.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

’Références

  1. Smith I, Procter M, Gelber RD, et al. (2007) 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial. Lancet 369: 29–36

    Article  PubMed  CAS  Google Scholar 

  2. Fisher B, Anderson S, Bryant J, et al. (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347: 1233–41

    Article  PubMed  Google Scholar 

  3. Clark R, McCullock P, Levine M, et al. (1992) Randomized clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer. J Natl Cancer Inst 84: 683–9

    Article  PubMed  CAS  Google Scholar 

  4. VanDongen JA, Voogd AC, Fentiman IS, et al. (2000) Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: EORTC 10801 trial. J Natl Cancer Inst 92: 1143–50

    Article  CAS  Google Scholar 

  5. Veronesi U, Cascinelli N, Mariani L, et al. (2002) Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347: 1227–32

    Article  PubMed  Google Scholar 

  6. Jacobson JA, Danforth DN, Cowan KH, et al. (1995) Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med 332: 907–11

    Article  PubMed  CAS  Google Scholar 

  7. Blichert-Toft M, Roce C, Anderson JA, et al. (1992) Danish randomized trial comparing breast conservation therapy with mastectomy: Six years of life table analysis. Danish Breast Cancer Cooperative group. J Natl Cancer Inst Monograms 11: 19–25

    Google Scholar 

  8. Arriagada R, Le MG, Guinebretiére JM, et al. (2003) Late local recurrences in a randomised trial comparing conservative treatment with total mastectomy in early breast cancer patients. Ann Oncol 14: 1617–22

    Article  PubMed  CAS  Google Scholar 

  9. Early Breast Cancer Trialists’ Collaborative Group (2000) Favorable and unfavorable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomized trials. Lancet 355: 1757–70

    Article  Google Scholar 

  10. Campana F, Kirova YM, Rosenwald JC, et al. (2005) Breast radiotherapy in the lateral decubitus position — a technique to prevent lung and heart irradiation. Int J Radiat Oncol Biol Phys 61(5): 1348–54

    Article  PubMed  Google Scholar 

  11. Kirova Y, Servois V, Campana F, et al. (2006) CT-scan based localization of the internal mammary chain and supra clavicular nodes for breast cancer radiation therapy planning. Radiother Oncol 79: 310–5

    Article  PubMed  Google Scholar 

  12. Grann A, McCormic B, Chabner ES, et al. (2000) Prone breast radiotherapy in earlystage breast cancer: a preliminary analysis. Int J Radiat Oncol Biol Phys 47: 319–25

    Article  PubMed  CAS  Google Scholar 

  13. Kirova YM, Campana F, Fournier-Bidoz N, et al. (2007) Postmastectomy electron beam chest wall irradiation in women with breast cancer: a clinical step towards conformal electron therapy. Int J Radiat Oncol Biol Phys 69: 1137–44

    Article  Google Scholar 

  14. Kirova YM, De Rycke Y, Gambotti L, et al. (2008) Second malignancies after breast cancer: the impact of different treatment modalities. Br J Cancer 98: 870–4

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  15. Campana F, Kirova YM, Zervoudis S, et al. (2007) Postmastectomy electron-beam chest wall irradiation in women with breast cancer: early and late complications. Gyneco Ro 3: 170–3

    Google Scholar 

  16. Kirova YM, Gambotti L, De Rycke Y, et al. (2007) Risk of second malignancies (SM) following adjuvant radiotherapy (RT) for breast cancer (BC): a large scale single institution review. Int J Radiat Oncol Biol Phys 68: 359–63

    Article  PubMed  Google Scholar 

  17. Kirova Y, Vilcoq JR, Asselain B, et al. (2005) Radiation-induced sarcomas (RIS) following radiotherapy for breast cancer: a large-scale single institution review. Cancer 104: 856–63

    Article  PubMed  Google Scholar 

  18. Kirova YM, Feuilhade F, Calitchi E, et al. (1998) Radiation-induced sarcomas following radiotherapy for breast cancer: six case reports and a review of the literature. Breast 7: 277–82

    Article  Google Scholar 

  19. Arimidex, Tamoxifen, Alone or in Combination (ATAC) Trialist’ Group et al. (2008) Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial. Lancet Oncol 9: 45–53

    Article  CAS  Google Scholar 

  20. Campone M, Roché H, Kerbrat P, et al. (2005) Secondary leukemia after epirubicin-based adjuvant chemotherapy in operable breast cancer patients: 16 years experience of the French Adjuvant Study Group. Ann Oncol 16: 1343–51

    Article  PubMed  CAS  Google Scholar 

  21. Beck A (1922) Zur Frage des Rontgenosarcomas Zugleich ein Beitrag zur Pathogenese des Sarcomas. Munch Med Wochenschr 69: 623–5

    Google Scholar 

  22. Brenin CM, Small W, Talamonti MS, Gradishar WJ (2002) Radiation-induced sarcoma following treatment of breast cancer. Cancer control 5: 425–32

    Google Scholar 

  23. De Vathaire F, Shamsaldin A, Grimaud E, Campbell S, et al. (1995) Solid malignant neoplasms after childhood irradiation: decrease of the relative risk with time after irradiation. C R Acad Paris 318: 483–90

    Google Scholar 

  24. Kirova Y, Rafi H, Voisin MC, et al. (2000) Radiation-induced bone sarcoma following total body irradiation: role of additional radiation on localized areas. Bone Marrow Transplantation 25: 1011–3

    Article  PubMed  CAS  Google Scholar 

  25. Warren S, Sommer GN (1936) Fibrosarcoma of the soft parts with special reference to recurrence and metastasis. Arch Surg 33: 425–50

    Article  Google Scholar 

  26. Cahan WG, Woodward HQ, Higinbothan NL, et al. (1948) Sarcoma arising in irradiated bone: report of eleven cases. Cancer 1: 3–29

    Article  PubMed  CAS  Google Scholar 

  27. Taghian A, de Vathaire F, Terrier P, et al. (1991) Long-term risk of sarcoma following radiation treatment for breast cancer. Int J Radiat Oncol Biol Phys 21: 361–7

    Article  PubMed  CAS  Google Scholar 

  28. Yap J, Chuba PJ, Thomas R, et al. (2002) Sarcoma as a second malignancy after treatment for breast cancer. Int J Radiat Oncol Biol Phys 52: 1231–7

    Article  PubMed  Google Scholar 

  29. Huang J, Mackillop WJ (2001) Increased risk of soft tissue sarcoma after radiotherapy in women with breast carcinoma. Cancer 82: 172–80

    Article  Google Scholar 

  30. Karlsson P, Holmberg E, Samuelsson A, et al. (1998) Soft tissue sarcoma after treatment for breast cancer-a Swedish population — based study. Eur J Cancer 34: 2068–75

    Article  PubMed  CAS  Google Scholar 

  31. Cozen W, Bernstein L, Wang F, et al. (1999) The risk of angiosarcoma following primary breast cancer. BJC 81: 532–6

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  32. Marchal C, Weber B, de Lafontan B, et al. (1999) Nine breast angiosarcomas after conservative treatment for breast carcinoma: a survey from French Comprehensive Cancer Centers. Int J Radiat Oncol Biol Phys 44: 113–9

    Article  PubMed  CAS  Google Scholar 

  33. Zukali R, Merson M, Placuci M, et al. (1994) Soft tissue sarcoma of the breast after conservative surgery and irradiation for early mammary cancer. Radiother Oncol 30: 271–3

    Article  Google Scholar 

  34. Doherty MA, Rodger A, Langlands AO (1986) Sarcoma of bone following therapeutic irradiation for breast carcinoma. Int J Radiat Oncol Biol Phys 12: 103–6

    Article  PubMed  CAS  Google Scholar 

  35. Pierce SM, Recht A, Lingos T (1992) Long term radiation complications following conservative surgery and radiation therapy in patients with early stage breast cancer. Int J Radiat Oncol Biol Phys 23: 915–23

    Article  PubMed  CAS  Google Scholar 

  36. Rao J, DeKoven JG, David Beatty J, Jones G (2003) Cutaneous angiosarcoma as a delayed complication of radiation therapy for carcinoma of the breast. J Am Acad Dermatol 49: 532–8

    Article  PubMed  Google Scholar 

  37. Karlsson P, Holmberg E, Johansson KA, et al. (1996) Soft tissue sarcoma after treatment for breast cancer. Radiother Oncol 38: 25–31

    Article  PubMed  CAS  Google Scholar 

  38. Stokkel MPM, Peterse HL (1995) Angiosarcoma of the breast after lumpectomy and radiation therapy for adenocarcinoma. Cancer 6: 2965–8

    Google Scholar 

  39. Mills TD, Vinnicombe SJ, Wells CA, et al. (2001) Angiosarcoma of the breast after wide local excision and radiotherapy for breast carcinoma. Clin Radiol 57: 63–74

    Article  Google Scholar 

  40. Wijnmaalen A, van Ooijen B, van Geel BN, et al. (1993) Angiosarcoma of the breast following lumpectomy, axillary lymph node dissection, and radiotherapy for primary breast cancer: 3 case reports and a review of the literature. Int J Radiat Oncol Biol Phys 2: 135–9

    Article  Google Scholar 

  41. ICRU Report 50 et ICRU Report 62 (Supplement to ICRU Report 50): Prescribing, Recording and Reporting Photon Beam Therapy, Issued 1999, Bethesda, Maryland, USA

    Google Scholar 

  42. Kaplan EL, Meier P (1958) Non-parametric estimation from incomplete observations. J Am Stat Assoc 53: 457–81

    Article  Google Scholar 

  43. Breslow NE, Day NE (1980) Statistical methods in cancer research. Volume I: The analysis of case control studies. IARC Scientific Publications no32, Lyon

    Google Scholar 

  44. Remontet L, Buemi A, Velten M, et al. (2003) Évolution de l’incidence et de la mortalité par cancer en France de 1978 á 2000. Rev Épidémiol Santé Publique 51 (1 pt 1): 3–30

    PubMed  CAS  Google Scholar 

  45. Stout AP, Lattres R (1967) Tumors of the soft tissues. Atlas of tumor Pathology, 2nd series. Armed Forces institute of Pathology, Washington DC

    Google Scholar 

  46. Sheppard DG, Libshitz HI (2001) Post-radiation sarcomas: a review of the clinical and imaging feature in 63 cases. Clin Radiol 56: 22–29

    Article  PubMed  CAS  Google Scholar 

  47. Valagussa P, Tancini G, Bonadonna G (1987) Second malignancies after CMF for respectable breast cancer. J Clin Oncol 5: 1138–42

    PubMed  CAS  Google Scholar 

  48. Dowd SB (1994) The practice of radiologic sciences. Radiol Technol 66: 32–3

    Google Scholar 

  49. Tubiana M (1983) Cancers par nuisance thérapeutiques: cancers et radiothérapie. Bull Cancer 70: 47–54

    PubMed  CAS  Google Scholar 

  50. Maruyama T, Kumamoto Y, Noda Y (1988) Reassessment of gamma doses from atomic bombs in Hiroshima and Nagasaki. Radiat Res 113: 1–14

    Article  PubMed  CAS  Google Scholar 

  51. Ishimaru M, Ishimaru T (1975) A review of 30 years study of Hiroshima and Nagasaki atomic bomb survivors. Biological effects. Leukemia and Related Disorders. J Radiat Res 16: S89–96

    Article  PubMed  Google Scholar 

  52. Hardy TJ, An T, Brown P, Terz JJ (1978) Postirradiation sarcoma (malignant fibrous histiocytoma) of axilla. Cancer 4: 118–24

    Article  Google Scholar 

  53. Rosen PP, Kimmel M, Ernsberger D (1988) Mammary angiosarcoma-the prognostic significance of tumor differentiation. Cancer 62: 2145–51

    Article  PubMed  CAS  Google Scholar 

  54. Wiklund TA, Blomqvist CP, Raty J, et al. (1991) Postirradiation sarcoma: analysis of a nation wide cancer registry material. Cancer 68: 524–31

    Article  PubMed  CAS  Google Scholar 

  55. Laskin WB, Silverman TA, Enzinger FM (1988) Postirradiation soft tissue sarcomas: an analysis of 53 cases. Cancer 62: 2330–40

    Article  PubMed  CAS  Google Scholar 

  56. Kim JH, Chu FCH, Woodward HQ, Huvos A (1983) Radiation induced sarcomas of bone following therapeutic radiation. Int J Radiat Oncol Biol Phys 9:107–10

    Article  PubMed  CAS  Google Scholar 

  57. Kuten A, Sapir D, Cohen Y, et al. (1985) Postirradiation soft tissue sarcoma occurring in breast cancer patients: report of seven cases and results of combination chemotherapy. J Surg Oncol 28: 168–71

    Article  PubMed  CAS  Google Scholar 

  58. Robinson E, Neugut A, Wylie P (1988) Review: clinical aspects of postirradiation sarcomas. J Nat Cancer Inst 80: 233–41

    Article  PubMed  CAS  Google Scholar 

Références

  1. Madelaine I (2008) Seconds Cancers. In: Dossier du CNIMH XXIX: 146

    Google Scholar 

  2. Hershman D, Neugut AI, Jacobson JS, et al. (2007) Acute myeloid leukaemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy. J Natl Cancer Inst 99: 196–205

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag France

About this chapter

Cite this chapter

Kirova, Y.M. (2010). Tumeurs secondaires: l’expérience du cancer du sein. In: Aider á vivre aprés un cancer. Oncologie pratique. Springer, Paris. https://doi.org/10.1007/978-2-287-79501-5_15

Download citation

  • DOI: https://doi.org/10.1007/978-2-287-79501-5_15

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-287-79500-8

  • Online ISBN: 978-2-287-79501-5

Publish with us

Policies and ethics